Facebook
Mon, May 01 - Thu, May 04 2017

World Intracranial Hemorrhage Conference,

Mt. Washington Conference Center, Baltimore, Maryland, United States Mt. Washington Conference Center, Baltimore, Maryland, United States
13 Sponsors Confirmed
Pfizer
CSL Behring
NINDS
Portola
ABC Associate Black Charities
NICO
Synaptive
EDGE
Boston Scientific

...

  • About the event

    It is our privilege to announce that the Johns Hopkins University will be hosting the 6th World Intracranial Hemorrhage Conference (WICH 2017) on May 1-3, 2017 in Baltimore, Maryland, United States. The Conference will feature highly respected speakers who will share, discuss, debate and dissect significant new developments and scientific advancements that will impact the future of intracranial hemorrhage. The planned program will provide learning opportunities for students, medical specialists and clinicians from all fields of endeavor, as well as world-class content for researchers and industry supporters.

    The main theme of the conference is "Accelerating Scientific Discoveries and Major Milestones in Intracranial Hemorrhage Therapeutics." The conference will lay a platform for the interaction between experts around the world and aims to encourage further research via the exchange of ideas between researchers and clinicians. The program will include all fields of intracranial hemorrhage, in order to understand the mechanisms behind these varied conditions and discuss how to improve their treatments. 

    Our international scientific program committee has developed an exciting single stream program that exposes participants to the most up-to-date aspects of intracerebral hemorrhage, subarachnoid hemorrhage, traumatic hemorrhage, and vascular malformations. The audience includes world leading basic scientists, epidemiologists, geneticists and clinicians making the program of the highest quality. 

    Baltimore is a beautiful place in May.  It is a wonderful site with opportunities to the rich mid-Atlantic region history from Colonial America to the industrial revolution and a modern day medical / biotech environment.  The conference site is conveniently located for those wishing to explore the cultural and touristic centers of Baltimore, Annapolis, Gettysburg, Harpers Ferry, and Washington DC. 

    On behalf of the Organizing Committee of WICH 2017, we look forward to welcoming all to Baltimore, Maryland, one of the United States' leading healthcare and medical research hubs – and to enjoy what we have to offer – a modern, state-of-the-art infrastructure, with a unique blend of the contemporary and traditional ways of life in our multi-racial, multi-cultural heritage.

    Daniel Hanley, MD

    Jeffrey and Harriet Legum Professor

    Acute Care Neurology

    Director, Division of Brain Injury Outcomes Service

    Johns Hopkins Medical Institute

    Magdy Selim, MD, PhD 

    Professor of Neurology    

    Harvard Medical School

    Chief, Division of Stroke & Cerebrovascular Disease    

    Beth Israel Deaconess Medical Center

    Why should you sponsor?

    The Conference will feature highly respected speakers who will share, discuss, debate and dissect significant new developments and scientific advancements that will impact the future of intracranial hemorrhage. The planned program will provide continuing education opportunities for students, medical specialists and clinicians from all fields of endeavor, as well as world-class content for researchers and industry supporters. The main theme of the conference is “Accelerating Scientific Discoveries and Major Milestones in Intracranial Hemorrhage Therapeutics.” The conference will lay a platform for the interaction between experts around the world and aims to encourage further research via the exchange of ideas between researchers and clinicians. The program will include all fields of intracranial hemorrhage, in order to understand the mechanisms behind these varied conditions and discuss how to improve their treatments.

    The conference will be followed by the first national HEADS meeting, which will assemble selected leaders from academia, scientists and research executives from industry, and government agencies responsible for drug & device regulation and research (NIH/NINDS and FDA),to collaboratively determine unmet needs and develop recommendations which address impediments to maximize opportunities for successfully, efficiently and rapidly mounting and completing hemorrhagic stroke studies encompassing the entire R&D process. 


    Jamie Braun

    Dr, Daniel Hanley

    Since 1996, I have been a Professor of Neurology, Neurosurgery and Anesthesia/Critical Medicine at Johns Hopkins Medical Institutions. Since 1999, I have also been Professor, School of Nursing, the Jeffrey and Harriett Legum Professor of Acute Care Neurology and Director of Brain Injury Outcomes Program at John s Hopkins Medical Institutions. I am a graduate of Williams College and Cornell University Medical College and has board certification in internal medicine, neurology and psychiatry. As a leading expert on multiple types of brain injury, I have received more than 40 clinical and basic research grants, predominately from the National Institute of Health and the FDA Orphan drugs program. I have published more than 225 articles in peer-reviewed journals, received the Alexander Humboldt Research Prize for my accomplishments in brain injury research and have extensive clinical trials experience in the fields of stroke, hemorrhage, trauma and brain infections. My trainees are directors of over 20 brain intensive care units across the United States. I have had extensive experience on public boards including American Academy of Neurology, the National Stroke Association, Nursing Institute of NIH, and NMT medical. I have significant experience in the areas of clinical trials design, organization and interpretation: drug development: device development and FDA regulatory compliance. I am the principle investigator for the NIH sponsored MISTIE and CLEAR trials investigating minimally invasive neurosurgical techniques to treat hemorrhagic stroke.

    Contact the Organizer Contact the Organizer

  • 101-250 attendees expected


    57% Male Attendees


    43% Female Attendees

Contact the Organizer

✓ Valid Invalid number

Select a Package

3 available packages from US$9000 to US$20000

US$9000
Unrestricted Conference Grant

• Sponsor’s logo with hyperlink on the Conference website • A 100-words company profile to be published in the Final Electronic Program • Promotion of the Sponsor with 1 special electronic newsletter • Opportunity to place 1 roll up of the Sponsor within the Conference Venue • Acknowledgement with the Sponsor’s logo on the Sponsors & Exhibitors Board during the Conference and also in the Final Program • Access to the HEADS Conference with 1 attendees

5 available

US$13000
Welcome Reception

Welcome Reception of the Conference will be help on May 1, 2017 with the attendance of all registered participants. Sponsor will have the opportunity to promote itself through this networking platform. Hospitality and any activities provided will be in compliance with relevant industry codes. • Sponsor’s logo on sign at the entrance to the Welcome Reception • Opportunity to provide items bearing company logo for use at the event • Access to the HEADS Conference with 1 attendee • Sponsor’s logo to be placed on the congress website with hyperlink of Sponsor’s company/product website • Support will be acknowledged in the Sponsorship and Exhibition section of the program, on the event website, with signage during the event, and also in the final program. • A 100-words company profile to be placed on the congress website, and to be published in the Final Program.

1 available

US$20000
Gala Dinner

Sponsor company will have the opportunity to promote through the Gala Dinner. • Sponsor’s banners to be placed at the Gala Dinner area and mini company flags to be placed on the tables • Sponsor’s logo to be placed in Conference publications with the phrase “Gala Dinner Sponsored by” • Sponsor’s logo to be placed on the congress website with hyperlink of Sponsor’s company/product website • Access to the HEADS Conference with 2 attendees • Support will be acknowledged in the Sponsorship and Exhibition section of the program, on the event website, with signage during the event, and also in the final program. • A 100-words company profile to be placed on the congress website, and to be published in the Final Program. • 10 complimentary invitations to the Gala Dinner for non-registered invitees of the sponsor company

1 available

This event contains prohibited content? Report it here.

Events that might interest you

Receive similar events to your mailbox?

Yes I want!

Contact the Organizer

✓ Valid Invalid number